2023
DOI: 10.3389/fimmu.2023.1285203
|View full text |Cite
|
Sign up to set email alerts
|

Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions

Cristina Capuano,
Davide De Federicis,
Daniel Ciuti
et al.

Abstract: IntroductionNatural Killer (NK) cells contribute to the protective effects of vaccine-induced antibodies thanks to the low affinity receptor for IgG, FcγRIIIA/CD16, whose aggregation leads to the killing of infected cells and IFNγ release, through which they potentiate adaptive immune responses.MethodsForty-seven healthy young individuals undergoing either homologous (ChAdOx1-S/ChAdOx1-S) or heterologous (ChAdOx1-S/BNT162B2) SARS-CoV-2 vaccination settings were recruited. Peripheral blood samples were collecte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 53 publications
(103 reference statements)
0
2
0
Order By: Relevance
“…For instance, a study comparing the effects of heterologous (ChAdOx1-S/BNT162b2) and homologous (ChAdOx1-S/ChAdOx1-S) vaccination schedules found a significant downregulation of CD16 exclusively in the group receiving the heterologous vaccine (ChAdOx1-S/BNT162b2). 45 Another study showed that NK cells exhibited potent ADCC function mediated by S2 antibodies after mRNA 1273 (Moderna) vaccination. 46 Other studies focused on patients with chronic virus infections.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For instance, a study comparing the effects of heterologous (ChAdOx1-S/BNT162b2) and homologous (ChAdOx1-S/ChAdOx1-S) vaccination schedules found a significant downregulation of CD16 exclusively in the group receiving the heterologous vaccine (ChAdOx1-S/BNT162b2). 45 Another study showed that NK cells exhibited potent ADCC function mediated by S2 antibodies after mRNA 1273 (Moderna) vaccination. 46 Other studies focused on patients with chronic virus infections.…”
Section: Discussionmentioning
confidence: 99%
“…However, other studies have explored NK cell responses to various types of vaccines, revealing modulation in both phenotype and function. For instance, a study comparing the effects of heterologous (ChAdOx1‐S/BNT162b2) and homologous (ChAdOx1‐S/ChAdOx1‐S) vaccination schedules found a significant downregulation of CD16 exclusively in the group receiving the heterologous vaccine (ChAdOx1‐S/BNT162b2) 45 . Another study showed that NK cells exhibited potent ADCC function mediated by S2 antibodies after mRNA 1273 (Moderna) vaccination 46 .…”
Section: Discussionmentioning
confidence: 99%